Reimbursement Assessment and Strategy

A Key Step Toward Market Access

A thoughtful reimbursement assessment supports widespread market access, commercial advantages, evidence generation, and patient access. Without a well-designed reimbursement strategy, even the most innovative therapies are unlikely to achieve market access, generate revenue, and benefit patients. When a thorough and high-quality assessment informs a meticulous reimbursement strategy, life sciences firms can achieve significant and sustained market access throughout a product’s lifecycle.

Full-Spectrum Services

Avalere’s reimbursement assessment and strategy services address the continuum of go-to-market responsibilities. We apply a holistic approach to the interlinked, overlapping activities of pre-launch planning, collaborating with clients to:

• Determine optimal regulatory pathways
• Calculate market size
• Establish where the product fits into the patient journey
• Assess payers’ willingness to pay
• Determine optimal payer mix and site of care mix
• Create a product-to-patient strategy

Throughout this process, we apply clinical, scientific, regulatory, and market access expertise to help our clients reach their target audiences and achieve successful launches. Our unrivaled analytic capabilities drive evidence-based decisions and draw from deep institutional, regulatory, and policy knowledge.